rs766553422
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000156.6(GAMT):c.662G>A(p.Arg221His) variant causes a missense change. The variant allele was found at a frequency of 0.0000372 in 1,611,700 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000156.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAMT | ENST00000252288.8 | c.662G>A | p.Arg221His | missense_variant | Exon 6 of 6 | 1 | NM_000156.6 | ENSP00000252288.1 | ||
GAMT | ENST00000640762.1 | c.593G>A | p.Arg198His | missense_variant | Exon 6 of 6 | 5 | ENSP00000492031.1 | |||
GAMT | ENST00000640164.1 | n.495G>A | non_coding_transcript_exon_variant | Exon 4 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247030Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134330
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1459504Hom.: 0 Cov.: 30 AF XY: 0.0000317 AC XY: 23AN XY: 726082
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74350
ClinVar
Submissions by phenotype
Deficiency of guanidinoacetate methyltransferase Uncertain:3
- -
GAMT NM_000156.5 exon 6 p.Arg221His (c.662G>A): This variant has not been reported in the literature and is present in 0.02% (5/23566) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/19-1397407-C-T). This variant is present in ClinVar (Variation ID:544254). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Uncertain:1
The c.662G>A (p.R221H) alteration is located in exon 6 (coding exon 6) of the GAMT gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
GAMT: PM2, PP3 -
Cerebral creatine deficiency syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 221 of the GAMT protein (p.Arg221His). This variant is present in population databases (rs766553422, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with GAMT-related conditions. ClinVar contains an entry for this variant (Variation ID: 544254). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GAMT protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at